A Clinical Investigation Core is an essential component of a multi- disciplinary HIV research program which fosters translational research through collaboration between clinical and basic scientists. Observations made in the basic science laboratory may merit validation and hypothesis may warrant testing with well characterized clinical specimens from HIV- infected patients. Diagnostic assays which are often developed from laboratory strains of organisms require evaluation with clinical isolates. Some translational research questions can be adequately addressed through analysis of stored specimens, but many require the prospective collection of fresh blood in select populations and specialized processing which is optimally coordinated and conducted by an experienced set of investigators and staff. The objective of the Clinical Investigation Core is to provide access of HIV patient specimens and clinical trials expertise to laboratory and clinical scientists studying HIV pathogenesis and associated opportunistic infections. A secondary objective of the Core is to provide access of specimens to investigators developing diagnostic assays for patient recruitment services including outreach to women, minorities and infection drug users, b) consultation on study design and analysis, c) acquisition of clinical specimens, and d) data entry and collection. The Clinical Investigation Core will promoter AIDS translational research by offering expert consultation by experiencing clinical investigators at an established HIV clinical research unit and access to participants in vaccine, anti-retroviral immune modulator, HIV primary infection, and opportunistic infection protocols. The Core will also permit the use of an established and experienced clinical research unit to obtain and distribute specimens for laboratory based research. The proposed Clinical Investigation Core will provide new opportunities for HIV investigators to study pathogenesis of HIV and associated infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI036214-08S1
Application #
6500687
Study Section
Project Start
2001-09-30
Project End
2002-05-31
Budget Start
Budget End
Support Year
8
Fiscal Year
2001
Total Cost
$180,480
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Giamouridis, Dimosthenis; Gao, Mei Hua; Lai, N Chin et al. (2018) Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal. JACC Basic Transl Sci 3:249-264
Jenks, Jeffrey D; Reed, Sharon L; Seidel, Danila et al. (2018) Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy. Int J Antimicrob Agents 52:706-712
Drumright, Lydia N; Weir, Sharon S; Frost, Simon D W (2018) The role of venues in structuring HIV, sexually transmitted infections, and risk networks among men who have sex with men. BMC Public Health 18:225
Francesconi, Walter; Berton, Fulvia; Marcondes, Maria Cecilia G (2018) HIV-1 Tat alters neuronal intrinsic excitability. BMC Res Notes 11:275
Lin, Timothy C; Gianella, Sara; Tenenbaum, Tara et al. (2018) A Simple Symptom Score for Acute Human Immunodeficiency Virus Infection in a San Diego Community-Based Screening Program. Clin Infect Dis 67:105-111
Saag, Michael S; Günthard, Huldrych F; Smith, Davey M (2018) Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment-Reply. JAMA 320:2154
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Arredondo, J; Gaines, T; Manian, S et al. (2018) The law on the streets: Evaluating the impact of Mexico's drug decriminalization reform on drug possession arrests in Tijuana, Mexico. Int J Drug Policy 54:1-8
Hoenigl, Martin; Orasch, Thomas; Faserl, Klaus et al. (2018) Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis. J Infect :
Moore, David J; Jain, Sonia; Dubé, Michael P et al. (2018) Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis 66:1566-1572

Showing the most recent 10 out of 921 publications